{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:44:51Z","timestamp":1759333491510},"reference-count":11,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":6429,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[1997,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this double\u2010blind, placebo\u2010controlled, comparative study was to differentiate the clinical efficacy and tolerability of human leukocyte interferon\u2010\u03b1 incorporated (2 times 10<jats:sup>6<\/jats:sup> IU\/g) in a hydrophilic cream and in a gel to heal males afflicted with first episodes of genital herpes. Patients (n=60), aged 18\u201340 years (mean 23.2) with culture\u2010confirmed diagnosis of herpes genitalis were randomized to three parallel groups. Each patient was allocated a precoded 40\u2010g tube, containing either preparation or placebo. Cream or gel was applied three times daily for 5 consecutive days. The duration of the active treatment was two weeks. Patients were examined after 48 hours of initial treatment, and thereafter two times a week. A reepithelialized lesion with some residual erythema was recorded as healed. The study demonstrated that patients treated with leukocyte interferon\u2010\u03b1 cream had both significantly shorter mean duration of lesions than gel and placebo recipients (5.3 days vs. 8 days, 13 days respectively; p&lt;0.001) and a higher number of healed patients (80% vs. 55%, 20% respectively; p&lt;0.001). Of the 60 patients, 49 (82%) complained of no drug\u2010related side effects. Eleven patients predominantly in the cream\/gel groups reported non\u2010objective transitory increase in their body temperature (&gt;38\u00b0C) with moderate headache, malaise and myalgia. The study was followed\u2010up for 24 months after the first day of the treatment, and out of 31\/60 cured patients, 4 had a relapse after 18 months.<\/jats:p><jats:p>In conlusion the study affirmed that human leukocyte interferon\u2010\u03b1 (2 times 10<jats:sup>6<\/jats:sup> IU\/g) in a hydrophilic cream is more efficacious than its incorporation in gel or placebo, thus suggesting that leukocyte interferon\u2010\u03b1 in a hydrophilic cream, with a profile of non\u2010objective mild to moderate drug\u2010induced indications, may be considered an alternative and effective treatment modality to cure male patients afflicated with first episodes of genital herpes.<\/jats:p>","DOI":"10.1111\/j.1346-8138.1997.tb02293.x","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T10:18:08Z","timestamp":1428661088000},"page":"564-568","source":"Crossref","is-referenced-by-count":8,"title":["Human Leukocyte Interferon\u2010\u03b1 in a Hydrophilic Cream <i>versus<\/i> in a Gel for the Treatment of Genital Herpes in Males: A Placebo\u2010Controlled, Double\u2010Blind, Comparative Study"],"prefix":"10.1111","volume":"24","author":[{"given":"Tanweer A.","family":"Syed","sequence":"first","affiliation":[{"name":"Department of Dermatology University of California  San Francisco U.S.A."},{"name":"Medical Faculty University of the Punjab  Lahore Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver Abbas","family":"Ahmadpour","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California  San Francisco U.S.A."},{"name":"University of Ume\u00e5  Ume\u00e5 Sweden"},{"name":"Medical Faculty University of the Punjab  Lahore Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Ali","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California  San Francisco U.S.A."},{"name":"Medical Faculty University of the Punjab  Lahore Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Hamzeh","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California  San Francisco U.S.A."},{"name":"Medical Faculty University of the Punjab  Lahore Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"s38","article-title":"The current trend in genital herpes. Progress in prevention","volume":"21","author":"Corey L","year":"1994","journal-title":"Sex Transm Dis"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246483"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00198242","article-title":"Human leukocyte interferon\u2010\u03b1 in cream for the management of genital herpes in Asian women. A placebo\u2010controlled, double\u2010blind study","volume":"73","author":"Syed TA","year":"1995","journal-title":"J Mol Med"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00190743"},{"key":"e_1_2_1_6_1","first-page":"43","volume-title":"Bench\u2010level laboratory manual for sexually transmited diseases","author":"Van Dyck E","year":"1989"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/jcm.26.4.662-667.1988","article-title":"Comparison of western blot (immunoblot) and glycoprotein G\u2010specific immunodot enzyme assay for detecting antibodies to herpes simplex types 1 and 2 in human sera","volume":"26","author":"Ashley RL","year":"1988","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_8_1","first-page":"29","volume-title":"Methods in Enzymology","author":"Cantell K","year":"1981"},{"key":"e_1_2_1_9_1","first-page":"499","volume-title":"Methods in Enzymology","author":"Cantell K","year":"1981"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6273.1345"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00189926"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246530"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.1997.tb02293.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.1997.tb02293.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T05:28:01Z","timestamp":1698384481000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.1997.tb02293.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["10.1111\/j.1346-8138.1997.tb02293.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.1997.tb02293.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}